Synergistic effect of angiotensin II and a high sodium diet on the vascular glycosaminoglycan synthesis of rats

American Journal of Hypertension

Volumn 10, Issue 11, 1997, Pages 1216-1222

  Simon, Geza ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Arteries; Extracellular matrix; High renin hypertension; Renovascular hypertension; Smooth muscle; Trophic effect; Veins

Indexed keywords

ANGIOTENSIN; GLYCOSAMINOGLYCAN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; GLYCOSAMINOGLYCAN METABOLISM; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE; STATISTICAL ANALYSIS;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; DIET; DRUG SYNERGISM; GLYCOSAMINOGLYCANS; HYPERTENSION, RENOVASCULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SODIUM, DIETARY; SULFUR RADIOISOTOPES; VASOCONSTRICTOR AGENTS;

EID: 0031279381     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00222-7     Document Type: Article

References (29)

1. 1. Muirhead EE, Leach BE, David JO, et al: Pathophysiology of angiotensin-salt hypertension. J Lab Clin Med 1975;85:734-745.
2. 2. Cowley AW, McCaa RE: Acute and chronic dose-response relationships for angiotensin, aldosterone and arterial pressure at varying levels of sodium intake. Circ Res 1976;39:788-797.
3. 3. Sato Y, Ogata E, Fujita T: Role of chloride in angiotensin II-induced salt-sensitive hypertension. Hypertension 1991;18:622-629.
4. 4. Hall JE: Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986;250:R960-R972.
5. 5. Lohmeier TE, Cowley AW: Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog. Circ Res 1979;44:154-160.
6. 6. Diz DI, Baer PG, Nasjletti A: Angiotensin II-induced hypertension in the rat. J Clin Invest 1983;72:466-471.
7. 7. Lachance D, Garcia R: Atrial natriuretic factor release by angiotensin II in the conscious rat. Hypertension 1988;11:502-508.
8. 8. Simon G, Abraham G, Cserep G: Pressor and subpressor angiotensin II administration: two experimental models of hypertension. Am J Hypertens 1995;8:645-650.
9. 9. Simon G: Stimulation of vascular Na-K pump with subpressor angiotensin II in rats. Proc Soc Exp Biol Med 1992;199:424-431.
10. 10. Simon G, Altman S: Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rat. J Hypertens 1992;10:1165-1171.
11. 11. Simon G, Abraham G, Altman S: Stimulation of vascular glycosaminoglycan synthesis by subpressor angiotensin II in rats. Hypertension 1994;23(suppl I):I-148-I-151.
12. 12. Haywood JR, Brennan TJ, Hinojosa C: Neurohumoral mechanisms of sodium-dependent hypertension. Fed Proc 1981;44:2393-2399.
13. 13. Battarbee HD, Dailey JW, Meneely GR: The interaction of dietary sodium and potassium with the adrenergic system and peripheral vasculature in sodium-induced hypertension, in Fregly MJ, Kare MR (eds): The Role of Sodium in Cardiovascular Hypertension. Academic Press, New York, 1982, pp 155-174.
14. 14. Jackson RL, Busch SJ, Cardin AD: Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev 1991;71:481-539.
15. 15. Friedman SM: Sodium in blood vessels: a brief review. Blood Vessels 1979;16:2-16.
16. 16. Simon G: Increased vascular wall sodium in hypertension: where is it, how does it get there and what does it do there? Clin Sci 1990;78:533-540.
17. 17. Zak R, Martin AF, Blough R: Assessment of protein turnover by use of radioisotopic tracers. Physiol Rev 1979;59:407-447.
18. 18. Spencer B: The ultramicro determination of inorganic sulphate. Biochem J 1960;75:435-440.
19. 4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Diabetes 1989;38:130-139.
20. 20. Nussberger J, Waeber B, Brunner HR: Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition. Am J Hypertens 1989;2:286-293.
21. 21. Griffin SA, Brown WCB, MacPherson F, et al: Angiotensin causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-635.
22. 35S]sulfate incorporation into aorta of spontaneously hypertensive rats. Collagen Rel Res 1986;6:103-120.
23. 23. Walker-Caprioglio HM, Koob TJ, McGuffee LJ: Proteoglycan synthesis in normotensive and spontaneously hypertensive rat arteries in vitro. Matrix 1992;12:308-320.
24. 24. Lipke DW, Couchman JR: Increased proteoglycan synthesis by the cardiovascular system of coarctation hypertensive rats. J Cell Physiol 1991;147:479-486.
25. 25. Dickinson CJ, Yu R: Mechanism involved in the progressive pressor response to very small amounts of angiotensin II. Circ Res 1967;20-21(suppl II):II-157-II-163.
26. 26. Brown JJR, Casals-Stenzel J, Gofford S, et al: Comparison of fast and slow pressor effects of angiotensin II. Am J Physiol 1981;241:H381-H388.
27. 27. Abraham G, Simon G: Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am J Hypertens 1994;7:269-275.
28. 28. Carey DJ: Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991;53:161-177.
29. 29. Lever AF: Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986;4:515-524.